We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Invited to Comment on EC Amendments to Licensing Regulation
Industry Invited to Comment on EC Amendments to Licensing Regulation
July 15, 2008
To cut through the red tape of what industry considers a burdensome regulation, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) wants public comment on the European Commission’s (EC) proposed changes to its centralized medicines legislation that deals with variations to licensed drugs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor